Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial Hypertension: Insights From the Phase III GRIPHON Study

BACKGROUND: NT-proBNP (N-terminal pro brain natriuretic peptide) levels are included in the multiparametric risk assessment approach for pulmonary arterial hypertension (PAH) outlined in PAH guidelines. However, data supporting the use of NT-proBNP risk thresholds in assessing prognosis in PAH are l...

Descripción completa

Detalles Bibliográficos
Autores principales: Chin, Kelly M., Rubin, Lewis J., Channick, Richard, Di Scala, Lilla, Gaine, Sean, Galiè, Nazzareno, Ghofrani, Hossein-Ardeschir, Hoeper, Marius M., Lang, Irene M., McLaughlin, Vallerie V., Preiss, Ralph, Simonneau, Gérald, Sitbon, Olivier, Tapson, Victor F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530970/
https://www.ncbi.nlm.nih.gov/pubmed/30982349
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.039360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530970/
https://www.ncbi.nlm.nih.gov/pubmed/30982349
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.039360

Ejemplares similares